Gallstone complications in sickle cell patients

被引:1
|
作者
Rambaud, E. [1 ]
Ranque, B.
Pouchot, J.
Arlet, J. -B.
机构
[1] Univ Paris Cite, Ctr Reference Syndromes Drepanocytaires Majeurs T, Serv Med Interne, 20 Rue Leblanc, F-75015 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2022年 / 43卷 / 08期
关键词
Sickle cell disease; Transfusion; Cholecystectomy; Vaso-occlusive crisis; Acute chest syndrome; Alloimmunization; AGGRESSIVE TRANSFUSION REGIMENS; ACUTE CHEST SYNDROME; ABDOMINAL-SURGERY; LAPAROSCOPIC CHOLECYSTECTOMY; PERIOPERATIVE MANAGEMENT; PROMOTER POLYMORPHISMS; SURGICAL-PROCEDURES; RISK-FACTORS; DISEASE; CHILDREN;
D O I
10.1016/j.revmed.2022.05.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic haemolysis exposes patients with sickle cell disease (SCD) to the development of black pigment gallstones, which can trigger biliary complications. In order to avoid these complications, elective cholecystectomy is recommended in France for all SCD patients with detected gallstones. However, all surgeries, and especially abdominal surgeries, entail an increased risk of vaso-occlusive complications in the peri- and post-operative periods, the most dreadful one being the acute chest syndrome. Preoperative transfusion has been shown in several studies to reduce acute postoperative complications, but exposes the patient to definitive alloimmunization, or even delayed post- transfusion haemolysis, justifying a recent trend towards transfusion sparing. The conditions for avoiding transfusion for a simple and frequent surgery such as cholecystectomy are based on a benefit- risk balance, and must be discussed on a case-by-case basis by the SCD specialist. In particular, it seems fully justified to perform prophylacticpreoperative transfusion in patients with a history of recent vaso-occlusive crisis or acute chest syndrome (within 6 months preoperatively), and those operated on in an emergency setting, who are particularly at risk of postoperative events. (c) 2022 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:479 / 486
页数:8
相关论文
共 50 条
  • [1] Cardiovascular complications in patients with sickle cell disease
    Gladwin, Mark T.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 423 - 430
  • [2] Cardiovascular complications in patients with sickle cell disease
    Chaturvedi, A.
    CANCER MEDICINE, 2018, 7 : 29 - 30
  • [3] Thromboembolic Complications in Patients with Sickle Cell Disease
    Alkindi, Salam
    Al-Ghadani, Anwaar
    Al-zeheimi, Samah
    Pathare, Anil
    BLOOD, 2018, 132
  • [4] Characterization of kidney complications in patients with sickle cell anemia
    Isaza-Lopez, M. C.
    Rojas-Rosas, L. F.
    Echavarria-Ospina, L.
    Serna-Higuita, L. M.
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2020, 91 (01): : 51 - 57
  • [5] Pulmonary complications in adult patients with sickle cell disease
    Sen, Nazan
    CUKUROVA MEDICAL JOURNAL, 2018, 43 (03): : 706 - 717
  • [6] Clinical Complications in Adult Patients with Sickle Cell Anemia and β-Thalassemia-Sickle Cell Disease
    Graziadei, Giovanna
    Marcon, Alessia
    Soldarini, Martina
    Gandolfi, Ilaria
    Ronzoni, Luisa
    Giuditta, Marianna
    Ridolfi, Pietro
    Cappellini, Maria Domenica
    BLOOD, 2012, 120 (21)
  • [7] Sickle cell disease complications
    Voskaridou, Ersi
    THALASSEMIA REPORTS, 2014, 4 (03) : 60 - 62
  • [8] Complications of Covid-19 on Sickle Cell Patients in Children
    Fadl, Ahmed Abdelsamie
    Balkhi, Duaa Salem
    Binyamien, Bayan Khalid
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (46A) : 559 - 565
  • [9] Complications of sickle cell disease
    Pena Gomez, Elena
    Vidal Trueba, Hector
    MEDICINA CLINICA, 2017, 148 (10): : 481 - 481
  • [10] Sickle cell trait complications: A case series of 6 patients
    Marcombes, C.
    Lafont, E.
    Jullien, V
    Flamarion, E.
    Dion, J.
    Costedoat-Chalumeau, N.
    Pouchot, J.
    Arlet, J. B.
    REVUE DE MEDECINE INTERNE, 2020, 41 (09): : 583 - 590